Drug Shortage Report for RESONIUM CALCIUM
| Report ID | 84937 |
| Drug Identification Number | 02017741 |
| Brand name | RESONIUM CALCIUM |
| Common or Proper name | Resonium Calcium |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM POLYSTYRENE SULFONATE |
| Strength(s) | 999MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL RECTAL |
| Packaging size | 1 |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-06-07 |
| Actual start date | |
| Estimated end date | 2019-09-30 |
| Actual end date | 2019-08-13 |
| Shortage status | Resolved |
| Updated date | 2019-10-15 |
| Company comments | The anticipated availability dates represent estimated availabilities at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-05-28 | English | Compare |
| v2 | 2019-05-28 | French | Compare |
| v3 | 2019-05-28 | English | Compare |
| v4 | 2019-05-28 | French | Compare |
| v5 | 2019-06-08 | English | Compare |
| v6 | 2019-10-15 | English | Compare |
| v7 | 2019-10-15 | French | Compare |
Showing 1 to 7 of 7